Literature DB >> 24216055

Nucleus tractus solitarii A(2a) adenosine receptors inhibit cardiopulmonary chemoreflex control of sympathetic outputs.

Zeljka Minic1, Donal S O'Leary1, Tadeusz J Scislo2.   

Abstract

Previously we have shown that stimulation of inhibitory A1 adenosine receptors located in the nucleus tractus solitarii (NTS) attenuates cardiopulmonary chemoreflex (CCR) evoked inhibition of renal, adrenal and lumbar sympathetic nerve activity and reflex decreases in arterial pressure and heart rate. Activation of facilitatory A2a adenosine receptors, which dominate over A1 receptors in the NTS, contrastingly alters baseline activity of regional sympathetic outputs: it decreases renal, increases adrenal and does not change lumbar nerve activity. Considering that NTS A2a receptors may facilitate release of inhibitory transmitters we hypothesized that A2a receptors will act in concert with A1 receptors differentially inhibiting regional sympathetic CCR responses (adrenal>lumbar>renal). In urethane/chloralose anesthetized rats (n=38) we compared regional sympathetic responses evoked by stimulation of the CCR with right atrial injections of serotonin 5HT3 receptor agonist, phenylbiguanide, (1-8μg/kg) before and after selective stimulation, blockade or combined blockade and stimulation of NTS A2a adenosine receptors (microinjections into the NTS of CGS-21680 0.2-20pmol/50nl, ZM-241385 40pmol/100nl or ZM-241385+CGS-21680, respectively). We found that stimulation of A2a adenosine receptors uniformly inhibited the regional sympathetic and hemodynamic reflex responses and this effect was abolished by the selective blockade of NTS A2a receptors. This indicates that A2a receptor triggered inhibition of CCR responses and the contrasting shifts in baseline sympathetic activity are mediated via different mechanisms. These data implicate that stimulation of NTS A2a receptors triggers unknown inhibitory mechanism(s) which in turn inhibit transmission in the CCR pathway when adenosine is released into the NTS during severe hypotension.
© 2013.

Entities:  

Keywords:  Adrenal nerve; Lumbar nerve; Nucleus of the solitary tract; Purinergic receptors; Renal nerve

Mesh:

Substances:

Year:  2013        PMID: 24216055      PMCID: PMC3947208          DOI: 10.1016/j.autneu.2013.10.005

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  65 in total

1.  Pressor response to chemoreflex activation before and after microinjection of glycine into the NTS of awake rats.

Authors:  Franklin F Pimentel; Leni G H Bonagamba; Benedito H Machado
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-12-05       Impact factor: 3.619

Review 2.  Vagal sensory receptors and their reflex effects.

Authors:  A S Paintal
Journal:  Physiol Rev       Date:  1973-01       Impact factor: 37.312

3.  Impulses in slowly conducting vagal fibers from afferent endings in the veins, atria, and arteries of dogs and cats.

Authors:  H M Coleridge; J C Coleridge; A Dangel; C Kidd; J C Luck; P Sleight
Journal:  Circ Res       Date:  1973-07       Impact factor: 17.367

4.  Characteristics of left ventricular receptors with nonmedullated vagal afferents in cats.

Authors:  P N Thorén
Journal:  Circ Res       Date:  1977-04       Impact factor: 17.367

5.  Dopamine modulates synaptic transmission in the nucleus of the solitary tract.

Authors:  David D Kline; Kristin N Takacs; Eckhard Ficker; Diana L Kunze
Journal:  J Neurophysiol       Date:  2002-11       Impact factor: 2.714

6.  Bezold-Jarisch reflex attenuates dynamic gain of baroreflex neural arc.

Authors:  Koji Kashihara; Toru Kawada; Yusuke Yanagiya; Kazunori Uemura; Masashi Inagaki; Hiroshi Takaki; Masaru Sugimachi; Kenji Sunagawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-24       Impact factor: 4.733

Review 7.  Adenosine receptors in the nervous system: pathophysiological implications.

Authors:  J A Ribeiro; A M Sebastião; A de Mendonça
Journal:  Prog Neurobiol       Date:  2002-12       Impact factor: 11.685

8.  Enhancement of carotid chemoreceptor reflex and cardiac chemosensitive reflex in the acute phase of myocardial infarction of the anesthetized rabbit.

Authors:  I Rocha; L B Rosário; E I de Oliveira; M A Barros; L Silva-Carvallho
Journal:  Basic Res Cardiol       Date:  2003-05       Impact factor: 17.165

9.  Resetting of cardiac C-fiber endings in the spontaneously hypertensive rat.

Authors:  P Thorén; E Noresson; S E Ricksten
Journal:  Acta Physiol Scand       Date:  1979-09

10.  Brain adenosine production in the rat during 60 seconds of ischemia.

Authors:  H R Winn; R Rubio; R M Berne
Journal:  Circ Res       Date:  1979-10       Impact factor: 17.367

View more
  5 in total

1.  NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

2.  Severe hemorrhage attenuates cardiopulmonary chemoreflex control of regional sympathetic outputs via NTS adenosine receptors.

Authors:  Zeljka Minic; Cailian Li; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

3.  Regadenoson for myocardial perfusion imaging: Is it safe?

Authors:  Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

4.  Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.

Authors:  Efstathia Andrikopoulou; Charity J Morgan; Lizbeth Brice; Navkaranbir S Bajaj; Harish Doppalapudi; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-10-17       Impact factor: 5.952

5.  Colocalization of A2a but not A1 adenosine receptors with GABA-ergic neurons in cardiopulmonary chemoreflex network in the caudal nucleus of the solitary tract.

Authors:  Zeljka Minic; Donal S O'Leary; Harry G Goshgarian; Tadeusz J Scislo
Journal:  Physiol Rep       Date:  2018-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.